- Home
- RWT vs PHVS Comparison
RWT vs PHVS Comparison
Compare RWT & PHVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RWT
- PHVS
- Stock Information
- Founded
- RWT 1994
- PHVS 2015
- Country
- RWT United States
- PHVS Switzerland
- Employees
- RWT N/A
- PHVS N/A
- Industry
- RWT Real Estate Investment Trusts
- PHVS Biotechnology: Pharmaceutical Preparations
- Sector
- RWT Real Estate
- PHVS Health Care
- Exchange
- RWT Nasdaq
- PHVS Nasdaq
- Market Cap
- RWT 756.1M
- PHVS 980.9M
- IPO Year
- RWT 1995
- PHVS 2021
- Fundamental
- Price
- RWT $5.95
- PHVS $22.99
- Analyst Decision
- RWT Buy
- PHVS Buy
- Analyst Count
- RWT 11
- PHVS 6
- Target Price
- RWT $7.55
- PHVS $37.17
- AVG Volume (30 Days)
- RWT 1.2M
- PHVS 59.1K
- Earning Date
- RWT 07-31-2025
- PHVS 08-13-2025
- Dividend Yield
- RWT 11.99%
- PHVS N/A
- EPS Growth
- RWT 105.35
- PHVS N/A
- EPS
- RWT 0.21
- PHVS N/A
- Revenue
- RWT $241,796,000.00
- PHVS N/A
- Revenue This Year
- RWT N/A
- PHVS N/A
- Revenue Next Year
- RWT $3.43
- PHVS N/A
- P/E Ratio
- RWT $28.46
- PHVS N/A
- Revenue Growth
- RWT 29.65
- PHVS N/A
- 52 Week Low
- RWT $4.68
- PHVS $11.51
- 52 Week High
- RWT $8.15
- PHVS $26.33
- Technical
- Relative Strength Index (RSI)
- RWT 54.41
- PHVS 67.31
- Support Level
- RWT $5.89
- PHVS $17.63
- Resistance Level
- RWT $6.18
- PHVS $26.33
- Average True Range (ATR)
- RWT 0.13
- PHVS 1.70
- MACD
- RWT 0.00
- PHVS 0.65
- Stochastic Oscillator
- RWT 58.77
- PHVS 65.24
About RWT Redwood Trust Inc.
Redwood Trust Inc is a real estate investment trust focused on different areas of housing credit. The company operates in three segments: Sequoia Mortgage Banking includes mortgage loan conduit that acquires residential consumer loans from third-party originators for sale to whole loan buyers and securitization; CoreVest Mortgage Banking segment includes consists of a platform that originates residential investor loans for securitization, sale, or transfer into Redwood Investments portfolio; and Redwood Investments segment consists of organic investments sourced through mortgage banking operations, including securities retained from Sequoia and CoreVest securitization activities. It derives maximum revenue from Redwood Investments segment.
About PHVS Pharvaris N.V.
Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.